A Seattle biotech company is working on a tweak to gene expression that could shut down hepatitis B (HBV), one of the viruses ...

Strong public health support and creating an open environment that enables MSM to follow recommendations will be crucial to ...

New Zealand approved Tune Therapeutics' TUNE-401, an epigenetic editing therapy for chronic hepatitis B, for human trials.

Arbutus Biopharma (ABUS) has released an update. Arbutus Biopharma is set to present at the Jefferies London Healthcare Conference to discuss ...

ROACH: I would like to know your opinion on the hepatitis B vaccine and its pros and cons. I'm a 39-year-old man who is thinking about potentially getting one. -- Anon. ANSWER: Hepatitis B is a viral ...

Research analyzing European survey data from 113,884 men who have sex with men (MSM) and published in Eurosurveillance ...

Research on HEPA-14 air purifiers in aged care reveals no significant impact on respiratory infections, though initial phase ...

Chronic viral hepatitis is the long-term inflammation of the liver. It is caused by hepatitis B, C or D virus particles. Even ...

Hepatitis B virus (HBV) vaccinations at birth help protect infants from HBV infection, making it generally safe for a person with a hepatitis B infection to breastfeed. Hepatitis B is a liver ...

The global hepatitis B diagnostic tests market is on the cusp of substantial expansion, driven by a combination of increasing disease incidence, heightened global awareness campaigns, and rapid ...

Pharma Two B and Hepion Pharmaceuticals (HEPA) announced that the U.S. Securities and Exchange Commission has declared effective the ...